Clinical Trial Update: Corneal Crosslinking for Treatment of Corneal Neovascularization [Phase 2, Phase 3]

View source ↗

Summary

This ClinicalTrials.gov entry reports that a Phase 2/Phase 3 study evaluating corneal crosslinking for treating corneal neovascularization is currently recruiti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Corneal Neovascularization

Snippet

Sponsor: Price Vision Group | Conditions: Corneal Neovascularization | Phase 2, Phase 3 | Status: RECRUITING